News Article 08-11-2013 | ConocoPhillips China Press Releases, News Articles
ConocoPhillips China and Children’s HeartLink Sign Agreement to Increase Access to Treatment for Children with Congenital Heart Disease in China
November 08, 2013
BEIJING – ConocoPhillips China today announced an agreement with Children’s HeartLink (CHL), a nonprofit organization based in the United States, to increase access to treatment at the West China Hospital of Sichuan University Hospital in Chengdu, China for children with congenital heart disease. Under the agreement, COPC will provide RMB 1,866,939 (USD $305,000) to Children’s HeartLink to support a three-year program that will increase the capacity of the hospital’s pediatric cardiac unit to treat and care for more children with congenital heart disease. The program will focus on increasing the number of pediatric cardiology and critical care staff by setting up training systems for pediatric cardiologists and cardiac intensive care physicians, as well as the creation of a comprehensive and specialized pediatric cardiac center. It will also support the hospital’s development as a regional training center, enabling it to reach a greater number of children by enhancing the expertise of more medical professionals. for cooperation in the future.” Children’s HeartLink has been working in partnership with West China Hospital since 2006 to promote sustainable cardiac care for children with congenital heart disease in China.
“ConocoPhillips is delighted to enter into this cooperation with Children’s HeartLink and the West China Hospital of Sichuan University,” said Jim Taylor, president, ConocoPhillips China. “We have a longstanding commitment to helping children across China who suffer from heart disease. Our newly formed partnership with Children’s HeartLink builds on the partnership we have had with the Love & Hope Project in Tianjin for six years that has helped 300 children suffering from congenital heart disease. As a committed partner of China, we are dedicated to supporting organizations that work to ensure the safety, health and wellbeing of citizens and families in need.”
- - - # # # - - -
About ConocoPhillips
ConocoPhillips is the world’s largest independent E&P company based on production and proved reserves. Headquartered in Houston, Texas, ConocoPhillips had operations and activities in 29 countries, $55 billion in annualized revenue, $120 billion of total assets, and approximately 18,000 employees as of Sept. 30, 2013. Production from continuing operations averaged 1,511 MBOED for the nine months ended Sept. 30, 2013, and proved reserves were 8.6 billion BOE as of Dec. 31, 2012. For more information, go to http://www.conocophillips.com.
About Children’s HeartLink
Founded in 1969, Children’s HeartLink is a nongovernmental organization partnering with health care centers in underserved regions of the world to improve access to pediatric cardiac care by building capacity and promoting sustainable cardiac care for children with congenital or acquired heart disease.
Children’s HeartLink currently supports partner hospitals and programs in the following countries: Brazil, China, India, Malaysia, Ukraine and Vietnam. Congenital heart disease is the world's most common major birth defect, affecting one in every 120 children. For more information on Children’s HeartLink, please visit http://www.childrensheartlink.org/.
Contacts
Donna Xue
ConocoPhillips China Inc.
Tel: 86-10-8453-8666 ext.6565
E-mail: rsccopcmedia@conocophillips.com
Helga Radio
Children’s HeartLink
+952.928.4860 ext. 15
E-mail: helga@childrensheartlink.org
CAUTIONARY STATEMENT FOR THE PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This news release contains forward-looking statements. Forward-looking statements relate to future events and anticipated results of operations, business strategies, and other aspects of our operations or operating results. In many cases you can identify forward-looking statements by terminology such as "anticipate," "estimate," "believe," "continue," "could," "intend," "may," "plan," "potential," "predict," "should," "will," "expect," "objective," "projection," "forecast," "goal," "guidance," "outlook," "effort," "target" and other similar words. However, the absence of these words does not mean that the statements are not forward-looking. Where, in any forward-looking statement, the company expresses an expectation or belief as to future results, such expectation or belief is expressed in good faith and believed to have a reasonable basis. However, there can be no assurance that such expectation or belief will result or be achieved. The actual results of operations can and will be affected by a variety of risks and other matters including, but not limited to, changes in commodity prices; changes in expected levels of oil and gas reserves or production; operating hazards, drilling risks, unsuccessful exploratory activities; difficulties in developing new products and manufacturing processes; unexpected cost increases; international monetary conditions; potential liability for remedial actions under existing or future environmental regulations; potential liability resulting from pending or future litigation; limited access to capital or significantly higher cost of capital related to illiquidity or uncertainty in the domestic or international financial markets; and general domestic and international economic and political conditions; as well as changes in tax, environmental and other laws applicable to our business. Other factors that could cause actual results to differ materially from those described in the forward-looking statements include other economic, business, competitive and/or regulatory factors affecting our business generally as set forth in our filings with the Securities and Exchange Commission. Unless legally required, ConocoPhillips undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.